Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0001954 | positive regulation of cell-matrix adhesion | 16/2508 | 51/18670 | 0.0007351 | 0.005951 | 0.004001 | 16 | RABC85 | |
BP | GO:0002526 | acute inflammatory response | 47/2508 | 220/18670 | 0.0007487 | 0.00605 | 0.004068 | 47 | RABC85 | |
BP | GO:0003012 | muscle system process | 87/2508 | 465/18670 | 0.0007497 | 0.00605 | 0.004068 | 87 | RABC85 | |
BP | GO:1903169 | regulation of calcium ion transmembrane transport | 35/2508 | 151/18670 | 0.0007523 | 0.00605 | 0.004068 | 35 | RABC85 | |
BP | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenti | 6/2508 | 10/18670 | 0.000755 | 0.00605 | 0.004068 | 6 | RABC85 | |
BP | GO:0048340 | paraxial mesoderm morphogenesis | 6/2508 | 10/18670 | 0.000755 | 0.00605 | 0.004068 | 6 | RABC85 | |
BP | GO:0097048 | dendritic cell apoptotic process | 6/2508 | 10/18670 | 0.000755 | 0.00605 | 0.004068 | 6 | RABC85 | |
BP | GO:2000668 | regulation of dendritic cell apoptotic process | 6/2508 | 10/18670 | 0.000755 | 0.00605 | 0.004068 | 6 | RABC85 | |
BP | GO:0034614 | cellular response to reactive oxygen species | 38/2508 | 168/18670 | 0.0007556 | 0.00605 | 0.004068 | 38 | RABC85 | |
BP | GO:0006898 | receptor-mediated endocytosis | 63/2508 | 316/18670 | 0.0007561 | 0.00605 | 0.004068 | 63 | RABC85 | |
BP | GO:0070542 | response to fatty acid | 23/2508 | 86/18670 | 0.0007595 | 0.006071 | 0.004081 | 23 | RABC85 | |
BP | GO:0072073 | kidney epithelium development | 33/2508 | 140/18670 | 0.0007701 | 0.006147 | 0.004133 | 33 | RABC85 | |
BP | GO:0002717 | positive regulation of natural killer cell mediated immunity | 12/2508 | 33/18670 | 0.0007721 | 0.006147 | 0.004133 | 12 | RABC85 | |
BP | GO:0070232 | regulation of T cell apoptotic process | 12/2508 | 33/18670 | 0.0007721 | 0.006147 | 0.004133 | 12 | RABC85 | |
BP | GO:0002440 | production of molecular mediator of immune response | 58/2508 | 286/18670 | 0.0007795 | 0.006178 | 0.004153 | 58 | RABC85 | |
BP | GO:0044262 | cellular carbohydrate metabolic process | 58/2508 | 286/18670 | 0.0007795 | 0.006178 | 0.004153 | 58 | RABC85 | |
BP | GO:0007045 | cell-substrate adherens junction assembly | 22/2508 | 81/18670 | 0.0007818 | 0.006178 | 0.004153 | 22 | RABC85 | |
BP | GO:0014855 | striated muscle cell proliferation | 22/2508 | 81/18670 | 0.0007818 | 0.006178 | 0.004153 | 22 | RABC85 | |
BP | GO:0048041 | focal adhesion assembly | 22/2508 | 81/18670 | 0.0007818 | 0.006178 | 0.004153 | 22 | RABC85 | |
BP | GO:0048708 | astrocyte differentiation | 22/2508 | 81/18670 | 0.0007818 | 0.006178 | 0.004153 | 22 | RABC85 | |
BP | GO:0006509 | membrane protein ectodomain proteolysis | 14/2508 | 42/18670 | 0.0007933 | 0.006253 | 0.004204 | 14 | RABC85 | |
BP | GO:0097028 | dendritic cell differentiation | 14/2508 | 42/18670 | 0.0007933 | 0.006253 | 0.004204 | 14 | RABC85 | |
BP | GO:0006790 | sulfur compound metabolic process | 72/2508 | 372/18670 | 0.0007974 | 0.006255 | 0.004205 | 72 | RABC85 | |
BP | GO:0003170 | heart valve development | 18/2508 | 61/18670 | 0.0007982 | 0.006255 | 0.004205 | 18 | RABC85 | |
BP | GO:0034113 | heterotypic cell-cell adhesion | 18/2508 | 61/18670 | 0.0007982 | 0.006255 | 0.004205 | 18 | RABC85 | |
BP | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 18/2508 | 61/18670 | 0.0007982 | 0.006255 | 0.004205 | 18 | RABC85 | |
BP | GO:0048844 | artery morphogenesis | 21/2508 | 76/18670 | 0.0007986 | 0.006255 | 0.004205 | 21 | RABC85 | |
BP | GO:0071466 | cellular response to xenobiotic stimulus | 40/2508 | 180/18670 | 0.0008068 | 0.006311 | 0.004243 | 40 | RABC85 | |
BP | GO:0046626 | regulation of insulin receptor signaling pathway | 19/2508 | 66/18670 | 0.0008087 | 0.006319 | 0.004248 | 19 | RABC85 | |
BP | GO:0032609 | interferon-gamma production | 28/2508 | 113/18670 | 0.0008208 | 0.006394 | 0.004299 | 28 | RABC85 |